MedPath

Ibuprofen

Generic Name
Ibuprofen
Brand Names
Addaprin, Advil, Advil Cold and Sinus, Advil Congestion Relief, Advil PM, Advil Sinus Congestion and Pain, Alivio, Caldolor, Cedaprin, Children's Ibuprofen, Diphen, Duexis, Ibu, Ibutab, Junior Strength Motrin, Motrin, Motrin PM, Neoprofen, Nuprin, Pedea, Proprinal, Reprexain, Sudafed PE Head Congestion Plus Pain, Vicoprofen, Wal-profen Congestion Relief and Pain, Ibuprofen Gen.Orph
Drug Type
Small Molecule
Chemical Formula
C13H18O2
CAS Number
15687-27-1
Unique Ingredient Identifier
WK2XYI10QM
Background

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.

Indication

Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.

The use of ibuprofen and its enantiomer Dexibuprofen in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.

Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.

As ibuprofen is a widely used medication, the main therapeutic indications are:

Associated Conditions
Acute Pain, Ankylosing Spondylitis (AS), Common Cold, Cystic Fibrosis (CF), Fever, Gastric Ulcer, Gout, Headache, Insomnia, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Migraine, Mild pain, Nasal Congestion, Osteoarthritis (OA), Pain, Pain, Inflammatory, Patent Ductus Arteriosus (PDA), Pericarditis, Primary Dysmenorrhoea, Rheumatoid Arthritis, Severe Pain, Sinus pressure, Mild to moderate pain, Minor aches and pains, Moderate Pain

Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction

Early Phase 1
Completed
Conditions
Pain, Acute
Pain, Post-operative
Third Molar
Oral Surgery
Interventions
First Posted Date
2024-07-03
Last Posted Date
2024-07-10
Lead Sponsor
United States Naval Medical Center, San Diego
Target Recruit Count
80
Registration Number
NCT06484439
Locations
🇺🇸

Naval Medical Center San Diego, San Diego, California, United States

Ibuprofen Use on Post-operative Pain Following Cholecystectomy

Phase 4
Completed
Conditions
Acute Post-operative Pain
Interventions
First Posted Date
2024-06-27
Last Posted Date
2024-06-27
Lead Sponsor
Giresun University
Target Recruit Count
71
Registration Number
NCT06478758
Locations
🇹🇷

Giresun University, Giresun, Turkey

Opioid Use After Laparoscopic Salpingectomy

Phase 4
Recruiting
Conditions
Opioid Use
Post-operative Pain
Sterility, Female
Interventions
First Posted Date
2024-05-30
Last Posted Date
2025-05-20
Lead Sponsor
Johns Hopkins University
Target Recruit Count
120
Registration Number
NCT06434233
Locations
🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Open-Label Placebo for Non-Specific Pain in the ED

Not Applicable
Recruiting
Conditions
Pain, Acute
Interventions
Other: Placebo (open-label)
First Posted Date
2024-05-10
Last Posted Date
2024-06-14
Lead Sponsor
Bruno Minotti
Target Recruit Count
50
Registration Number
NCT06408519
Locations
🇨🇭

University Hospital Basel, Basel, Switzerland

A Study to Investigate the Analgesic Efficacy of Ibuprofen Alone and Ibuprofen Plus Hyoscine-n- Butyl Bromide in Reducing Pain of Outpatient Hysteroscopy

Phase 4
Not yet recruiting
Conditions
Pain
Interventions
First Posted Date
2024-05-03
Last Posted Date
2024-05-10
Lead Sponsor
ASST Fatebenefratelli Sacco
Target Recruit Count
190
Registration Number
NCT06398054

Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea

Phase 3
Completed
Conditions
Primary Dysmenorrhea
Interventions
First Posted Date
2024-03-19
Last Posted Date
2025-02-21
Lead Sponsor
Lahore Medical Research Center, LLP
Target Recruit Count
40
Registration Number
NCT06317064
Locations
🇵🇰

Prof. Dr. Riffat Mehboob, Lahore, Punjab, Pakistan

Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat

Phase 1
Completed
Conditions
Acute Kidney Injury
Interventions
First Posted Date
2024-02-08
Last Posted Date
2024-02-08
Lead Sponsor
University of New Mexico
Target Recruit Count
12
Registration Number
NCT06247462
Locations
🇺🇸

Exercise Physiology Lab, Albuquerque, New Mexico, United States

Gynecologic Endoscopic Surgery of Female Motion Sickness Patients

Phase 4
Completed
Conditions
Motion Sickness
Postoperative Nausea and Vomiting
Ibuprofen
Interventions
First Posted Date
2024-01-31
Last Posted Date
2024-01-31
Lead Sponsor
Second Hospital of Jilin University
Target Recruit Count
66
Registration Number
NCT06232785
Locations
🇨🇳

Second Hospital of Jilin University, Changchun, Jilin, China

Efficacy of a Standardized Centella Asiatica Extract in Patients With Temporomandibular Disorder

Phase 2
Completed
Conditions
Temporomandibular Disorder
Interventions
First Posted Date
2024-01-30
Last Posted Date
2024-02-07
Lead Sponsor
Chulalongkorn University
Target Recruit Count
23
Registration Number
NCT06231212
Locations
🇹🇭

Chulalongkorn University, Bangkok, Thailand

Low Level Diode Laser Versus Topical Chamomile in Management of Chemotherapy Induced Oral Mucositis

Phase 2
Not yet recruiting
Conditions
Chemotherapy Induced Oral Mucositis
Interventions
First Posted Date
2024-01-19
Last Posted Date
2024-01-23
Lead Sponsor
Cairo University
Target Recruit Count
45
Registration Number
NCT06214273
© Copyright 2025. All Rights Reserved by MedPath